LAIR-1-binding agents and methods of use thereof
US12240899B2 · kind B2 · utility
0Cited by
8References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Aug 17, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides binding agents, such as antibodies, that specifically bind LAIR-1, including human LAIR-1, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.